In clinical research, the occurrence of certain events (e.g., adverse events, disease progression, relapse, or death) is often of particular interest to the investigators, especially in the area of cancer trials. In most situations, these events are undesirable and unpreventable. In practice, it would be beneficial to patients if the test treatment could delay the occurrence of such events. As ...
